Imatinib-Resistant CML Cells Have Low ENT Activity but Maintain Sensitivity to Gemcitabine

por Leisewitz, Andrea V., Zimmerman, Eric I., Jones, Shannon Z., Yang, Jing, Graves, Lee M.
Publicado em 2008

Sorafenib Metabolism, Transport, and Enterohepatic Recycling: Physiologically Based Modeling and Simulation in Mice

por Edginton, Andrea N., Zimmerman, Eric I., Vasilyeva, Aksana, Baker, Sharyn D., Panetta, John C.
Publicado no Cancer Chemother Pharmacol (2016)

MULTICOLOR MONITORING OF DYSREGULATED PROTEIN KINASES IN CHRONIC MYELOGENOUS LEUKEMIA

por Wang, Qunzhao, Zimmerman, Eric I., Toutchkine, Alexei, Martin, Timothy D., Graves, Lee M., Lawrence, David S.
Publicado em 2010

Regulation of ENT1 Expression and ENT1-Dependent Nucleoside Transport by c-Jun N-terminal Kinase

por Leisewitz, Andrea V., Zimmerman, Eric I., Huang, Min, Jones, Shannon Z., Yang, Jing, Graves, Lee M.
Publicado em 2010

1480. Plasma and Urine Pharmacokinetic Analysis of Gepotidacin (GSK2140944) Following BID Oral Dosing in a Phase IIa Study for Treatment of Uncomplicated Urinary Tract Infections

por Zimmerman, Eric I, Dumont, Etienne, Perry, Caroline R, Tiffany, Courtney, Scangarella-Oman, Nicole, Raychaudhuri, Aparna, Hossain, Mohammad
Publicado no Open Forum Infect Dis (2019)

Hippocampal interneurons are abnormal in schizophrenia

por Konradi, Christine, Yang, C. Kevin, Zimmerman, Eric I., Lohmann, Kathryn M., Gresch, Paul, Pantazopoulos, Harry, Berretta, Sabina, Heckers, Stephan
Publicado em 2011

Hippocampal interneurons in bipolar disorder

por Konradi, Christine, Zimmerman, Eric I., Yang, C. Kevin, Lohmann, Kathryn M., Gresch, Paul, Pantazopoulos, Harry, Berretta, Sabina, Heckers, Stephan
Publicado em 2010

Contribution of OATP1B1 and OATP1B3 to the Disposition of Sorafenib and Sorafenib-Glucuronide

por Zimmerman, Eric I., Hu, Shuiying, Roberts, Justin L., Gibson, Alice A., Orwick, Shelley J., Li, Lie, Sparreboom, Alex, Baker, Sharyn D.
Publicado em 2013

Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region

por Wang, Alice Y., Lohmann, Kathryn M., Yang, C. Kevin, Zimmerman, Eric I., Pantazopoulos, Harry, Herring, Nicole, Berretta, Sabina, Heckers, Stephan, Konradi, Christine
Publicado em 2011

Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia

por Zimmerman, Eric I., Dollins, Claudia M., Crawford, Melissa, Grant, Steven, Nana-Sinkam, Serge P., Richards, Kristy L., Hammond, Scott M., Graves, Lee M.
Publicado em 2010

Ontogeny and sorafenib metabolism

por Zimmerman, Eric I., Roberts, Justin L., Li, Lie, Finkelstein, David, Gibson, Alice, Chaudhry, Amarjit S., Schuetz, Erin G., Rubnitz, Jeffrey E., Inaba, Hiroto, Baker, Sharyn D.
Publicado em 2012

Crenolanib is active against models of drug-resistant FLT3-ITD−positive acute myeloid leukemia

por Zimmerman, Eric I., Turner, David C., Buaboonnam, Jassada, Hu, Shuiying, Orwick, Shelley, Roberts, Michael S., Janke, Laura J., Ramachandran, Abhijit, Stewart, Clinton F., Inaba, Hiroto, Baker, Sharyn D.
Publicado em 2013

Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemia

por Baker, Sharyn D., Zimmerman, Eric I., Wang, Yong-Dong, Orwick, Shelley, Zatechka, Douglas S., Buaboonnam, Jassada, Neale, Geoffrey A., Olsen, Scott R., Enemark, Eric J., Shurtleff, Sheila, Rubnitz, Jeffrey E., Mullighan, Charles G., Inaba, Hiroto
Publicado em 2013

Multi-kinase inhibitors induce cutaneous toxicity through OAT6-mediated uptake and MAP3K7-driven cell death

por Zimmerman, Eric I., Gibson, Alice A., Hu, Shuiying, Vasilyeva, Aksana, Orwick, Shelley J., Du, Guoqing, Mascara, Gerard P., Ong, Su Sien, Chen, Taosheng, Vogel, Peter, Inaba, Hiroto, Maitland, Michael L., Sparreboom, Alex, Baker, Sharyn D.
Publicado no Cancer Res (2015)

Application of Multiplexed Kinase Inhibitor Beads to Study Kinome Adaptations in Drug-Resistant Leukemia

por Cooper, Matthew J., Cox, Nathan J., Zimmerman, Eric I., Dewar, Brian J., Duncan, James S., Whittle, Martin C., Nguyen, Thien A., Jones, Lauren S., Ghose Roy, Sreerupa, Smalley, David M., Kuan, Pei Fen, Richards, Kristy L., Christopherson, Richard I., Jin, Jian, Frye, Stephen V., Johnson, Gary L., Baldwin, Albert S., Graves, Lee M.
Publicado em 2013